Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparison of the biomarkers for targeted therapies in primary extra-mammary and mammary Paget's disease.

Cancer medicine - 1 Feb 2020

Gatalica Zoran, Vranic Semir, Krušlin Božo, Poorman Kelsey, Stafford Phillip, Kacerovska Denisa, Senarathne Wijendra, Florento Elena, Contreras Elma, Leary Alexandra, Choi April, In Gino K

Abstract excerpt

BACKGROUND: Primary Extra-mammary Paget's disease (EMPD) is a very rare cutaneous adenocarcinoma affecting anogenital or axillary regions. It is characterized by a prolonged course with recurrences and eventually distant metastatic spread for which no specific therapy is known. METHODS: Eighteen EMPD (13 vulvar and five scrotal) and ten mammary Paget's disease (MPD) cases were comprehensively profiled for gene...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast
Share to Gene Amplification

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Microsatellite Instability

Share to Molecular Targeted Therapy

Share to Precision Medicine

Share to Scrotum

Source

Open in PubMed Open full text

Identifiers

PMID: 31899853
DOI: 10.1002/cam4.2820
PMCID: PMC7013075

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparison of the biomarkers for targeted therapies in primary extra-mammary and mammary Paget's disease.PMID 31899853Read ↗

Unbiased Detection of Driver Mutations in Extramammary Paget Disease.Semantic proximity Read ↗

Genomic Alterations as Potential Therapeutic Targets in Extramammary Paget’s Disease of the VulvaSemantic proximity Read ↗

Identification of genetic alterations in extramammary Paget disease using whole exome analysisSemantic proximity Read ↗

Association of genetic alterations with prognosis in extramammary Paget disease: insights into the involvement of somatic CDKN2A variants in patients with a poor prognosis.Semantic proximity Read ↗

Single-cell RNA sequencing provides insights into the potential cellular origins and microenvironment of Extramammary Paget's disease.Semantic proximity Read ↗

Extramammary Paget's disease patient-derived xenografts harboring ERBB2 S310F mutation show sensitivity to HER2-targeted therapies.Semantic proximity Read ↗

Case report: Primary vulvar adenocarcinoma of mammary gland type—its genetic characteristics by focused next-generation sequencingSemantic proximity Read ↗

A review of reviews of the prevalence of molecular biomarkers in vulvar cancer and their implications for prognosis refinement and treatment strategies.Semantic proximity Read ↗

Prevalence of extramammary Paget’s disease in urban China: a population-based studySemantic proximity Read ↗

Treatment of metastatic extramammary Paget's disease associated with adnexal adenocarcinoma, with anti-HER2 drugs based on genomic alteration ERBB2 S310F.Semantic proximity Read ↗

Risk factors and molecular characterization of penile cancer: impact on prognosis and potential targets for systemic therapy.Semantic proximity Read ↗

Identification of potentially druggable molecular alterations in skin adnexal malignanciesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.